CD8A and central nervous system cancer: For example, the lncRNA HOXA-AS2 promotes Treg proliferation and immune tolerance in glioma (24), and LINC00887 promotes clear cell renal cell carcinoma progression by inhibiting the infiltration of CD8+ T cells (25).